美国指南在短程结核病预防疗法方面存在不足。
US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
机构信息
Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
出版信息
Clin Infect Dis. 2024 Mar 20;78(3):514-517. doi: 10.1093/cid/ciad659.
Abstract
The provision of tuberculosis-preventive therapy (TPT) to vulnerable populations is critical for global control. Shorter-course TPT regimens are highly effective and improve completion rates. Despite incorporation of 1 month of rifapentine and isoniazid into global guidelines, current US TPT guidelines do not include this as a recommended regimen, but should.
摘要
为弱势群体提供结核病预防性治疗（TPT）对于全球控制至关重要。较短疗程的 TPT 方案非常有效，并提高了完成率。尽管在全球指南中纳入了利福平吡嗪酰胺 1 个月方案，但目前美国的 TPT 指南并未将其作为推荐方案，但应该这样做。
相似文献
1
US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.美国指南在短程结核病预防疗法方面存在不足。
Clin Infect Dis. 2024 Mar 20;78(3):514-517. doi: 10.1093/cid/ciad659.
2
Cost-effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda.在乌干达，接受抗逆转录病毒治疗的人群中，每日使用异烟肼和利福喷丁一个月与每周使用异烟肼和利福喷丁三个月预防结核病的成本效益比较。
J Int AIDS Soc. 2020 Oct;23(10):e25623. doi: 10.1002/jia2.25623.
3
One-month daily and three-month weekly rifapentine plus isoniazid are comparable in completion rate and safety for latent tuberculosis infection in non-HIV Population: a randomized controlled trial.一个月每日和三个月每周利福喷丁加异烟肼治疗非 HIV 人群潜伏性结核感染的完成率和安全性相当：一项随机对照试验。
Clin Microbiol Infect. 2024 Nov;30(11):1410-1417. doi: 10.1016/j.cmi.2024.06.024. Epub 2024 Jul 10.
4
Treatment Responses to Integrase Strand-transfer Inhibitor-containing Antiretroviral Regimens in Combination With Short-course Rifapentine-based Regimens for Latent Tuberculosis Infection Among People With HIV.含整合酶链转移抑制剂的抗逆转录病毒方案联合短程利福平为基础方案治疗 HIV 感染者潜伏性结核感染的治疗反应。
Clin Infect Dis. 2024 May 15;78(5):1295-1303. doi: 10.1093/cid/ciad730.
5
Treatment of latent tuberculosis infection.潜伏结核感染的治疗。
Ther Adv Respir Dis. 2013 Dec;7(6):351-6. doi: 10.1177/1753465813503028. Epub 2013 Sep 20.
6
Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine.潜伏性结核感染的治疗完成情况：一项回顾性队列研究，比较9个月异烟肼、4个月利福平以及3个月异烟肼和利福喷汀的治疗效果。
BMC Infect Dis. 2017 Feb 14;17(1):146. doi: 10.1186/s12879-017-2245-8.
7
Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study.利福喷丁单药与联合异烟肼治疗潜伏性结核感染的疗效比较：转化药代动力学-药效学模型研究。
Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0170521. doi: 10.1128/AAC.01705-21. Epub 2021 Oct 4.
8
An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study.一项在英格兰进行的针对潜伏性结核感染治疗的利福喷汀与利福平短程方案对照、开放性标签、随机对照试验：HALT LTBI 研究。
BMC Infect Dis. 2021 Jan 21;21(1):90. doi: 10.1186/s12879-021-05766-9.
9
Cost of Delivering 12-Dose Isoniazid and Rifapentine Versus 6 Months of Isoniazid for Tuberculosis Infection in a High-Burden Setting.在高负担环境下，提供 12 剂量异烟肼和利福喷丁与 6 个月异烟肼治疗结核病感染的成本。
Clin Infect Dis. 2021 Sep 7;73(5):e1135-e1141. doi: 10.1093/cid/ciaa1835.
10
Tuberculosis Preventive Treatment.结核病预防治疗。
Indian J Pediatr. 2024 Aug;91(8):823-829. doi: 10.1007/s12098-023-04969-z. Epub 2023 Dec 14.
引用本文的文献
1
Tuberculosis Infection in People Living with Human Immunodeficiency Virus: Challenges and Solutions.HIV 感染者中的结核分枝杆菌感染：挑战与对策。
Viruses. 2024 Aug 14;16(8):1295. doi: 10.3390/v16081295.
2
Acute Leukemia and Latent Tuberculosis Infection in Italy: Quantiferon-Tb Test Screening in a Low Tuberculosis Incidence Country.意大利的急性白血病与潜伏性结核感染：在结核病低发病率国家进行的结核感染T细胞检测筛查
Mediterr J Hematol Infect Dis. 2024 Jul 1;16(1):e2024054. doi: 10.4084/MJHID.2024.054. eCollection 2024.
本文引用的文献
1
Impact and cost-effectiveness of short-course tuberculosis preventive treatment for household contacts and people with HIV in 29 high-incidence countries: a modelling analysis.29 个高负担国家中针对 HIV 感染者和其家庭接触者开展短程结核预防治疗的影响和成本效益：建模分析。
Lancet Glob Health. 2023 Aug;11(8):e1205-e1216. doi: 10.1016/S2214-109X(23)00251-6.
2
Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.贝达喹啉-普托马尼德-利奈唑胺方案治疗耐药结核病。
N Engl J Med. 2022 Sep 1;387(9):810-823. doi: 10.1056/NEJMoa2119430.
3
Evaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States.评价美国公共卫生诊所潜伏性结核病护理环节。
Clin Infect Dis. 2022 Nov 14;75(10):1792-1799. doi: 10.1093/cid/ciac248.
4
Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022.临时指南：4 个月利福喷丁-莫西沙星方案治疗药物敏感性肺结核 - 美国，2022 年。
MMWR Morb Mortal Wkly Rep. 2022 Feb 25;71(8):285-289. doi: 10.15585/mmwr.mm7108a1.
5
Latent Tuberculosis Infection.潜伏性结核感染
N Engl J Med. 2021 Dec 9;385(24):2271-2280. doi: 10.1056/NEJMcp2108501.
6
Short-course daily isoniazid and rifapentine for latent tuberculosis infection in people living with HIV who received coformulated bictegravir/emtricitabine/tenofovir alafenamide.每日短程异烟肼和利福喷丁治疗接受比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺联合治疗的 HIV 感染者潜伏性结核感染。
J Int AIDS Soc. 2021 Nov;24(11):e25844. doi: 10.1002/jia2.25844.
7
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.利福喷丁四个月方案联合或不联合莫西沙星治疗结核病。
N Engl J Med. 2021 May 6;384(18):1705-1718. doi: 10.1056/NEJMoa2033400.
8
Safety and feasibility of 1 month of daily rifapentine plus isoniazid to prevent tuberculosis in children and adolescents: a prospective cohort study.1 个月每日利福喷丁加异烟肼预防儿童和青少年结核病的安全性和可行性：一项前瞻性队列研究。
Lancet Child Adolesc Health. 2021 May;5(5):350-356. doi: 10.1016/S2352-4642(21)00052-3. Epub 2021 Mar 24.
9
Cost-effectiveness of one month of daily isoniazid and rifapentine versus three months of weekly isoniazid and rifapentine for prevention of tuberculosis among people receiving antiretroviral therapy in Uganda.在乌干达，接受抗逆转录病毒治疗的人群中，每日使用异烟肼和利福喷丁一个月与每周使用异烟肼和利福喷丁三个月预防结核病的成本效益比较。
J Int AIDS Soc. 2020 Oct;23(10):e25623. doi: 10.1002/jia2.25623.
10
Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial.每周一次利福喷丁和异烟肼用于接受多替拉韦为基础的抗反转录病毒治疗的 HIV 感染者的结核病预防：一项 1/2 期试验。
Lancet HIV. 2020 Jun;7(6):e401-e409. doi: 10.1016/S2352-3018(20)30032-1. Epub 2020 Mar 30.
Zotero 插件